Adaptive Biotechnologies vs Tempus AI
Adaptive Biotechnologies vs Tempus AI, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and Tempus AI on 55/100.
Where each one leads
Adaptive Biotechnologies
- our overall score: 69/100 against 55/100
- agent readiness: 39/100 against 21/100
Tempus AI
- domain rating: 72/100 against 62/100
- funding raised: $380M against $300M
At a glance
| Measure | Adaptive Biotechnologies | Tempus AI |
|---|---|---|
| What it is | Leveraging the adaptive immune system to diagnose and treat disease. | AI-enabled precision medicine platform using clinical and molecular data to improve patient outcomes. |
| Category | Biotech, HealthTech, Genomics, Drug Discovery | AI, Healthcare, Biotech, Precision Medicine |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | services | platform | Platform |
| Founded | 2009 | 2015 |
| Headquarters | Seattle, United States | Chicago, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptive Biotechnologies | Tempus AI |
|---|---|---|
| Total funding | $300M | $380M |
| Latest round | Series D | Series F |
| Valuation | Not published | $3.1B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptive Biotechnologies | Tempus AI |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 55/100 |
| Traction | Not published | 40/100 |
| Team | Not published | 30/100 |
| Search visibility | Not published | 22/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 62/100 | 72/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptive Biotechnologies | Tempus AI |
|---|---|---|
| Hosting | Self Managed | Vercel |
| CDN | Not detected | Vercel |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
Adaptive Biotechnologies vs Tempus AI: common questions
Which is better, Adaptive Biotechnologies or Tempus AI?
On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Adaptive Biotechnologies and Tempus AI compare on the numbers?
Adaptive Biotechnologies leads on our overall score (69/100 against 55/100), agent readiness (39/100 against 21/100). Tempus AI leads on domain rating (72/100 against 62/100), funding raised ($380M against $300M).
Read the full Adaptive Biotechnologies review and pricing or the Tempus AI review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.